All articles tagged with #testicular cancer
ABC News correspondent Will Reeve, 34, confirmed he is cancer-free after treating embryonal testicular cancer. He disclosed the diagnosis in April 2026, just months after his wedding, and underwent surgery and chemotherapy at Memorial Sloan Kettering. Reeve used a recent Good Morning America segment to destigmatize the disease and express gratitude for his wife's support.
ABC News correspondent Will Reeve, 34, disclosed a diagnosis of embryonal testicular cancer in April 2026. He underwent an orchiectomy in May, a lymph node dissection in June, and two rounds of chemotherapy in July at Memorial Sloan Kettering. As of September 8, he is cancer-free.
ABC News correspondent Will Reeve, 34, publicly disclosed a diagnosis of embryonal testicular cancer in April 2026, just months after his wedding. He underwent an orchiectomy in May, a lymph node dissection in June, and two cycles of chemotherapy in July at Memorial Sloan Kettering. Clean scans on September 8 confirmed he is now cancer-free.
Will Reeve, 34, son of late actor Christopher Reeve and a correspondent for ABC News, publicly disclosed a diagnosis of embryonal testicular cancer in April 2026. He underwent an orchiectomy in May, a lymph node dissection in June, and two cycles of chemotherapy in July at Memorial Sloan Kettering. Clean scans received on September 8 confirmed he is now cancer-free. Reeve shared the news on Good Morning America to destigmatize the disease and highlight the importance of early detection.
Will Reeve, a 34-year-old correspondent for ABC News and Good Morning America, has publicly disclosed that he was diagnosed with testicular cancer in April 2026. The diagnosis came shortly after his January wedding. Reeve underwent an orchiectomy in May, followed by a lymph node dissection in June and two cycles of chemotherapy in July. He is now cancer-free and aims to raise awareness about the disease.
ABC News correspondent Will Reeve, 34, publicly disclosed his diagnosis of embryonal testicular cancer in April 2026, just months after his January wedding. Following an orchiectomy in May, he underwent a lymph node dissection in June and two cycles of chemotherapy at Memorial Sloan Kettering in July. Reeve stated that the treatment reduced his recurrence risk to nearly 1% and aims to raise awareness about the disease.
Nate Shalom, a 27-year-old fitness enthusiast and entrepreneur from St. Petersburg, Florida, was diagnosed with stage 2 testicular cancer in June 2026. Despite an active lifestyle and no family history of cancer, Shalom experienced testicular, abdominal, and back pain that he initially dismissed. A conversation with Kathy Lemoine, whose son died of colon cancer, prompted him to seek medical attention. After an initial misdiagnosis of infection by a urologist, an ultrasound and MRI confirmed a mass and lymph node spread. Shalom underwent surgery to remove his right testicle and is currently undergoing chemotherapy, highlighting the importance of early symptom recognition in young, healthy individuals.
A urologist explains the two main roles of the testes (sperm production and testosterone), how they descend into the scrotum for cooler temperatures, and what’s normal (slight differences between testicles, the epididymis, and the spermatic cord). It covers not-normal signs (a firm, painless lump can indicate cancer, while pain or swelling may be epididymitis or torsion), the importance of early evaluation, and the typical workup (exam, ultrasound, urine tests, tumor markers; MRI if needed). The piece emphasizes regular self-exams in the shower to establish a baseline and urges men not to delay care if something changes.
Testicular cancer is rising among men aged 15–49 (about 2,400 UK cases per year). Risk factors include family history, undescended testicles, and possibly early chemical exposure; white ethnicity is linked to higher risk. Common symptoms are a lump or swelling, with pain in about 10% of cases. Early detection is crucial, as cure rates exceed 95%. Treatment usually removes the affected testicle, with chemotherapy if needed; newer robotic lymph-node surgery speeds recovery, as highlighted by Sam Birchall’s experience.
Denver Broncos linebacker Alex Singleton announced he has testicular cancer and underwent surgery, causing him to miss upcoming games. Despite his diagnosis, Singleton played through the pain in the previous game, and his absence will impact the team's defense, which will rely on Dre Greenlaw and Justin Strnad. Strnad may take on additional leadership responsibilities, and the team is rallying around Singleton as he fights his illness, with a key game against the Kansas City Chiefs upcoming.
Broncos linebacker Alex Singleton underwent surgery for testicular cancer after a diagnosis revealed a tumor following a league-mandated drug test; he is optimistic about a full recovery and emphasizes the importance of regular screenings.
Oklahoma City Thunder guard Nikola Topic has been diagnosed with testicular cancer and is undergoing chemotherapy, but he remains in good spirits and continues to be involved with the team, with a positive long-term outlook according to doctors.
Oklahoma City Thunder guard Nikola Topic has started chemotherapy after being diagnosed with testicular cancer, with doctors optimistic about his prognosis. The 20-year-old player, who was recovering from an ACL tear, is focusing on his health, and there is no set timeline for his return to basketball.
Doctors warn that testicular cancer is rising among men aged 20-40, with low awareness and screening rates, despite high treatability when caught early. The disease affects about 1 in 270 young men annually, and early detection through self-exams is crucial for a high survival rate of 95%. Notable cases include athletes Lance Armstrong and Nathan Adrian, highlighting the importance of awareness and timely diagnosis.
Prostate and testicular cancer survivors Aaron Watson and Ken McBride are urging men to discuss and be aware of symptoms related to these cancers. Watson, diagnosed with testicular cancer at 22, emphasizes the importance of early detection and open conversations about men's health. McBride, who experienced prostate cancer symptoms, is participating in a research trial. Prostate cancer is the most common cancer in men, with early detection significantly improving outcomes. The NHS is reviewing its testing guidelines following calls for increased awareness and testing.